<DOC>
	<DOCNO>NCT00762905</DOCNO>
	<brief_summary>To evaluate effectiveness , safety , utility LiquiBand Laparoscopic™ relation currently approve active control product ( High Viscosity DermaBond ) . Specifically , study power demonstrate LiquiBand Laparoscopic™ inferior DermaBond rate infection , dehiscence , cosmesis apposition skin .</brief_summary>
	<brief_title>Clinical Trial MedLogic LiquiBand Laparoscopic Versus Dermabond Closure Surgical Incisions</brief_title>
	<detailed_description>This prospective , randomize , control , double-masked multi-center clinical trial . Patients require laparoscopic surgery enrol randomize receive either LiquiBand Laparoscopic™ DermaBond High Viscosity incision closure . No closure method allow . All eligible laparoscopic incision per patient enrol . Patients follow 2 week 3 month post-procedure ass wound characteristic , wound infection , wind dehiscence 3 month cosmesis . The study double-masked wound evaluator patient mask randomized study treatment assignment .</detailed_description>
	<criteria>Scheduled laparoscopic surgical procedure Aged 18 year old Agree return 2weeks ( 3 day ) postprocedure followup visit Agree return 3month ( 5 day ) postprocedure followup visit Able willing give inform consent comply study requirement Known sensitivity cyanoacrylate , formaldehyde acetone product , Surgical procedure involve mucus membrane eye History skin rash exfoliative condition time procedure History keloid formation hypertrophy Currently immunosuppressive therapy Decubitus ulcer Pregnant nursing . Participated investigational drug device study within past 3 month Conditions know interfere wound healing : Diabetes , Type I II Advanced chronic renal insufficiency ( GFR great 25 mL/min clinical sign azotemia ) , uremia endstage renal disease Advanced liver failure cirrhosis ( ChildPugh score B C ) Advanced malignancy , cancer patient currently receive chemotherapy ( within 30 day procedure ) History radiation therapy study area Advanced COPD ( FEV great 1 litre PaO2 60 mmHg ) Suspected infection incision site Peripheral vascular disease Corticosteroid therapy Morbid obesity ( 50100 percent 100 pound ideal body weight and/or BMI value great 40 ) Blood clot disorder ( e.g . Haemophilia ) Wounds high tension force ( joint ) Life expectancy great 3 month ASA level 4 5</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>cyanoacrylate</keyword>
	<keyword>LiquiBand Laparoscopic</keyword>
	<keyword>Dermabond</keyword>
	<keyword>The rate complete dermal apposition</keyword>
	<keyword>The rate wound infection wind dehiscence</keyword>
	<keyword>The rate optimal cosmesis</keyword>
</DOC>